Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000432866

Medchemexpress LLC Omeprazole sodium | 95510-70-6 | MFCD07802816 | 99.10% | C17H18N3NaO3S | 500 MG
SDP

Catalog No. 5000432866
Encompass_Preferred

Omeprazole sodium is a proton pump inhibitor (PPI) used in the treatment of acid-related gastrointestinal disorders. It competitively inhibits CYP2C19 activity with a Ki of 2 to 6 μM. It also inhibits the growth of both Gram-positive and Gram-negative bacteria, and is a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor).

  • Proton pump inhibitor (PPI)
  • Treats acid-related gastrointestinal disorders
  • Competitively inhibits CYP2C19 activity with a Ki of 2 to 6 μM
  • Inhibits growth of Gram-positive and Gram-negative bacteria
  • Potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor)
  • Utilized in the study of dyspepsia, peptic ulcer disease, gastroesophageal reflux disease, laryngopharyngeal reflux, and Zollinger-Ellison syndrome

Catalog No. 50-004-32866 Supplier Medchemexpress LLC Supplier No. HYB0113A500MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Omeprazole sodium is a proton pump inhibitor (PPI) used in the treatment of acid-related gastrointestinal disorders. It competitively inhibits CYP2C19 activity with a Ki of 2 to 6 μM. It also inhibits the growth of both Gram-positive and Gram-negative bacteria, and is a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor).

  • Proton pump inhibitor (PPI)
  • Treats acid-related gastrointestinal disorders
  • Competitively inhibits CYP2C19 activity with a Ki of 2 to 6 μM
  • Inhibits growth of Gram-positive and Gram-negative bacteria
  • Potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor)
  • Utilized in the study of dyspepsia, peptic ulcer disease, gastroesophageal reflux disease, laryngopharyngeal reflux, and Zollinger-Ellison syndrome

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.